Experiments were performed on groups of rats after acute and sub-chronic tr
eatment (once daily for 9 days) with the cannabinoid agonist HU 210 (25-100
mu g kg(-1), i.p.) as well as 24 h and 7 days after the last drug injectio
n. The animals underwent three behavioural tests in novel environments. In
the observation cages (Test 1), rat locomotor activity was found to be dose
-dependently reduced after acute and sub-chronic treatment at all doses and
virtually unchanged during abstinence; grooming was potently inhibited by
acute treatment but potentiated by the sub-chronic one at doses of 50 and 1
00 mu g kg(-1), the effect of the higher dose persisting after 24 h and 7 d
ays abstinence. Vocalization in animals in response to a tactile stimulus w
as highest after HU 210 at 100 mu g kg(-1) in all experimental modes except
after 7 days abstinence. In the X-maze (Test 2), sub-chronic HU 210 dose-d
ependently enhanced rat natural aversion for open arms, and this behaviour
persisted during abstinence after the highest dose. Grooming in the X-maze
was completely absent in rats acutely injected with HU 210 but potentiated
in those sub-chronically treated or abstinent. In the swimming test (Test 3
) rats sub-chronically treated at 50 and 100 pg kg(-1) displayed relevant w
all-hugging and the same occurred 24 h after last injection. On the whole,
our results are indicative of an anxiogenic-like effect of sub-chronic HU 2
10 at high doses and reflect the persistence of enhanced emotional response
to novel environments when the treatment is discontinued. (C) 2000 Academi
c Press.